Press Release

ZSX Medical to Present Uterine Closure Innovation at IMPACT 2010 -- Northeast Venture Conference to Learn of Zip- Stitch™ Pre-Fabricated Closure System

Philadelphia, PA, October 20, 2010: At 11:30AM, Wednesday November 10, 2010, Dan Mazzucco, Ph.D., President of ZSX Medical, will present ZSX Medical, LLC's concept to revolutionize surgical closure through prefabricated bio-absorbable polymer systems. “It is our intention”, notes Dr. Mazzucco, “to make closing large surgical incisions as easy as closing a Zip-Loc® bag.”

“Designed in consultation with obstetrical surgeons, the first iteration of the Zip-Stitch™ platform will address uterine closure following cesarean delivery," said Dr. Mazzucco. "In a typical cesarean delivery, the uterus is bleeding and open to infection for about ten minutes. Zip-Stitch™ is designed to reduce that critical time of uterine expsure by up to 80%, improving patient outcomes and reducing hospital costs.”

Cesarean delivery is an obvious first target for Zip-Stitch™ as cesareans have become the most common large incision surgery in the world. One third of babies are delivered by cesarean in the U.S. and over ten million world-wide.  A major reason for that prevalence is poor uterine healing from a prior cesarean delivery necessitating cesarean for subsequent pregnancies.  Zip-Stitch™ hopes to give doctors the confidence to recommend a vaginal birth after cesarean (VBAC) to those mothers who desire it.

“Doctors with whom we’ve spoken urge us to make Zip-Stitch™ available to their hospitals as quickly as possible and that is why we are appearing at IMPACT 2010," said Dr. Mazzucco. "This is the perfect environment for our revolutionary platform to attract Medical industry investors who can speed our path to market.”

 

About ZSX Medical, LLC

ZSX Medical, LLC is a pre-clinical stage medical device company reinventing surgical closure through proprietary bio-absorbable systems. ZSX products will feature reduced operative time, infection, tissue adhesion and dehiscence in comparison to sutures or staples, freeing surgeons to focus on the procedure at hand. Our debut product, named Zip-Stitch™ to reflect both its ease of use and speed of closure, will revolutionize uterine closure in the $50 billion global cesarean market. Zip-Stitch™ is the only product designed specifically for uterine closure in cesarean delivery, so it is the only product that meets all the needs of the procedure. Subscribe to our newsletter and learn more about us at www.ZipStitch.com .

About IMPACT 2010

PACT’s annual venture conference, IMPACT 2010, is the most established venture conference in the northeast. For over 20 years, IMPACT has been showcasing the best and most promising investment opportunities in the Technology, Life Sciences, and Clean Technology sectors. IMPACT’s Featured Companies have raised more than a $1 billion in venture financing and are some of the region’s most recognizable names. Hosted by KPMG LLP, IMPACT 2010 will be held on November 9 & 10 in Philadelphia.